| 注册
首页|期刊导航|中国医学创新|68例稳定期慢性阻塞性肺疾病患者的临床治疗研究

68例稳定期慢性阻塞性肺疾病患者的临床治疗研究

米热尼沙·阿不都热西提 迪丽拜尔·达吾提

中国医学创新Issue(29):25-26,27,3.
中国医学创新Issue(29):25-26,27,3.DOI:10.3969/j.issn.1674-4985.2013.29.012

68例稳定期慢性阻塞性肺疾病患者的临床治疗研究

Clinical Study of 68 Patients with Stable Chronic Obstructive Pulmonary Disease

米热尼沙·阿不都热西提 1迪丽拜尔·达吾提1

作者信息

  • 1. 新疆喀什地区结核病防治所 新疆 喀什 844000
  • 折叠

摘要

Abstract

Objective:To investigate the clinical curative effect of seretide in treatment of chronic obstructive pulmonary disease(COPD)in stable phase.Method:68 patients who had be attacked by a disease of COPD in stable phase from our hospital were randomly selected and divided into control group(33 cases)and observation group(35 cases). The control group were given an expectorant such as the ambroxol hydrochloride capsules and theophylline sustained-release tablets for conventional oral treatment.The observation group patients added Seretide inhalation treatment on the basis of control group. The clinical efficacy of the two groups were compared after treatment for one year. Result:After one year treatment,the degree of dyspnea improved obviously and the clinical symptom score decreased significantly of the observation group(P<0.05).At the same time,FEV1( the forced expiratory volume in 1 second),FEV1/FVC(%)(forced expiratory volume in 1 second for FVC%)and FEV1 percentage of predicted value(%)of the patients in the observation group after treatment increased significantly(P<0.05),while the control group was no statistical significance(P>0.05). Conclusion:Inhaling Seretide is sure and safe in treatment of COPD patients in stable phase,worthy of clinical application.

关键词

稳定期/慢性阻塞性肺疾病/舒利迭/疗效

Key words

Stable/Chronic obstructive pulmonary disease/Seretide/Curative effect of seretide

引用本文复制引用

米热尼沙·阿不都热西提,迪丽拜尔·达吾提..68例稳定期慢性阻塞性肺疾病患者的临床治疗研究[J].中国医学创新,2013,(29):25-26,27,3.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文